HMGB1 and chronic myelogenous leukemia, BCR-ABL1 positive: CML-HMGB1 activated cancer-associated signals, such as RAGE, AKT, and NF-κB, exceeding the effect of oxidized HMGB1, and promoted proliferation, invasion, survival, stemness, and drug resistance development.